Israeli cancer patients resume hunger strikeBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7567.517-a (Published 07 September 2006) Cite this as: BMJ 2006;333:517
- Merav Sarig
Patients with colorectal cancer and their families have renewed a hunger strike in front of the Knesset building in Jerusalem to protest against the exclusion of Erbitux (cetuximab) from the health insurance benefits package. They maintain that when they ended their previous strike they were promised that the drug would be included.
Four months ago, patients with colorectal cancer mounted the strike to protest at the exclusion of Avastin (bevacizumab) and cetuximab from a package of treatments which included only “life saving” rather than “life prolonging” chemotherapy alongside preventive measures (BMJ 2006;332:1352, 10 Jun). Politicians …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial